Ambu A/S (AMBU-B) - Total Liabilities
Based on the latest financial reports, Ambu A/S (AMBU-B) has total liabilities worth Dkr1.50 Billion DKK (≈ $235.47 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore AMBU-B net asset momentum to track the company's year-over-year net asset growth rate.
Ambu A/S - Total Liabilities Trend (2002–2025)
This chart illustrates how Ambu A/S's total liabilities have evolved over time, based on quarterly financial data. See AMBU-B cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Ambu A/S Competitors by Total Liabilities
The table below lists competitors of Ambu A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
OneSpaWorld Holdings Ltd
NASDAQ:OSW
|
USA | $148.13 Million |
|
K+S Aktiengesellschaft
F:SDF1
|
Germany | €2.81 Billion |
|
Winner Medical Co Ltd
SHE:300888
|
China | CN¥5.93 Billion |
|
IRB Infrastructure Developers Limited
NSE:IRB
|
India | Rs339.66 Billion |
|
Shanghai Phichem Material Co Ltd Class A
SHE:300398
|
China | CN¥1.96 Billion |
|
Ratch Group Public Company Limited
BK:RATCH
|
Thailand | ฿130.36 Billion |
|
Eurazeo
PA:RF
|
France | €1.70 Billion |
|
Kaiser Aluminum Corporation
NASDAQ:KALU
|
USA | $1.91 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Ambu A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ambu A/S market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ambu A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ambu A/S (2002–2025)
The table below shows the annual total liabilities of Ambu A/S from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | Dkr1.64 Billion ≈ $256.59 Million |
+5.13% |
| 2024-09-30 | Dkr1.56 Billion ≈ $244.07 Million |
+6.41% |
| 2023-09-30 | Dkr1.47 Billion ≈ $229.37 Million |
-50.37% |
| 2022-09-30 | Dkr2.95 Billion ≈ $462.17 Million |
+65.21% |
| 2021-09-30 | Dkr1.79 Billion ≈ $279.75 Million |
-29.99% |
| 2020-09-30 | Dkr2.55 Billion ≈ $399.59 Million |
+7.49% |
| 2019-09-30 | Dkr2.38 Billion ≈ $371.74 Million |
+1.02% |
| 2018-09-30 | Dkr2.35 Billion ≈ $367.99 Million |
+92.63% |
| 2017-09-30 | Dkr1.22 Billion ≈ $191.03 Million |
-11.14% |
| 2016-09-30 | Dkr1.37 Billion ≈ $214.97 Million |
+12.81% |
| 2015-09-30 | Dkr1.22 Billion ≈ $190.56 Million |
+2.10% |
| 2014-09-30 | Dkr1.19 Billion ≈ $186.65 Million |
-2.53% |
| 2013-09-30 | Dkr1.22 Billion ≈ $191.50 Million |
+325.88% |
| 2012-09-30 | Dkr287.40 Million ≈ $44.97 Million |
-7.08% |
| 2011-09-30 | Dkr309.30 Million ≈ $48.39 Million |
-1.58% |
| 2010-09-30 | Dkr314.27 Million ≈ $49.17 Million |
+4.05% |
| 2009-09-30 | Dkr302.04 Million ≈ $47.26 Million |
+7.79% |
| 2008-09-30 | Dkr280.21 Million ≈ $43.84 Million |
+6.71% |
| 2007-09-30 | Dkr262.59 Million ≈ $41.08 Million |
-8.40% |
| 2006-09-30 | Dkr286.67 Million ≈ $44.85 Million |
-7.19% |
| 2005-09-30 | Dkr308.87 Million ≈ $48.32 Million |
+13.99% |
| 2004-09-30 | Dkr270.97 Million ≈ $42.40 Million |
+3.45% |
| 2003-09-30 | Dkr261.92 Million ≈ $40.98 Million |
-6.21% |
| 2002-09-30 | Dkr279.25 Million ≈ $43.69 Million |
-- |
About Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as… Read more